Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Do Probiotics Modulate the Intestinal Microbiome of Extremely Preterm Infants?

NCT03422562 is registered in ClinicalTrials.gov with Belal Alshaikh as lead sponsor.

NCT NCT03422562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03422562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Do Probiotics Modulate the Intestinal Microbiome of Extremely Preterm Infants?
Lead sponsor
Belal Alshaikh
Phase
Phase 3
Overall status
Completed
Start date
October 26, 2017
Completion date
April 26, 2021
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microbial colonization